Follow US:
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
A UC Riverside-led study, funded by Merck, is set to find out
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Host campus UC Riverside will be joined by UC Davis and UC Merced
Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist
Neural crest study results could boost stem cell therapies
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
A program to test a smartphone-based COVID-19 exposure notification system will expand to an additional five University of California campus locations, including UC Riverside, as a result of success from an initial deployment earlier this fall at two UC campuses. The program is a joint effort between the UCs and...
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Policy has limited impact on vaccine uptake because of individual decision making, study finds
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
As the fall quarter begins, UC Riverside has a new diagnostic lab operating on campus that will rapidly process samples from students and employees as part of an ongoing coronavirus testing program. The lab, located at the Multidisciplinary Research Building, or MRB, tested its first sample in August and opened...
UC Riverside mouse study focused on neurons in the hippocampus
Osmotic therapy device reduces swelling to prevent secondary injuries in rats
Andrew Subica and Ann Cheney will focus their research on marginalized U.S. populations
Inland Empire Health Plan’s gift of $2.6M will create up to 23 awards designed to encourage students to practice in the region
Content developed by School of Medicine for physicians and other health care professionals includes grand rounds and a journal club delivered virtually
UC Riverside-led study identifies mechanism that prevents death of neurons
